Tag:
osteoporosis
Latest Headlines
Latest Headlines
More evidence supports fracture risk with long-term bisphosphonate use
A new study found that bisphosphonate drugs used to treat osteoporosis significantly increase the risk of severe upper-thigh fractures, and the risk grows with longer-term use of the drugs.
FDA review questions long-term use of bone-building drugs
The FDA is giving women a lot to chew on with a new analysis of long-term use of drugs for osteoporosis because they can, although rarely, have a debilitating effect.
Postmenopausal osteoporosis fingerprinted by miRNAs
Researchers at Creighton University, NE, have linked a circulating miRNA, a small stretch of genetic material, to post-menopausal osteoporosis and are considering links with three genes.
Osteoporosis drug developer Radius Health braves chilly IPO market
After burning through more than $122 million, the late-stage osteoporosis drug developer Radius Health is filing to go public in the hope of raising up to $86 million. Radius is betting that it can
Radius Health pulls in $21.4M more for Phase III bone drug
Investors plowed another big chunk of capital into startup Radius Health as the company funds an ongoing pivotal study for its bone-building drug for osteoporosis, a bone-thinning ailment that
FDA panel wants bone drugs' labeling changed, but how?
What to do about the potential risks of bisphosphonates? An FDA advisory panel wasn't exactly sure. At a meeting last week, the agency's expert committee voted to change the labeling on these popular
DoD gives NeoStem $1.7M to develop adult stem cells for osteoporosis
NeoStem, a New York-based biopharmaceutical company, has been awarded almost $1.8 million from the U.S. Department of Defense to develop the company's Very Small Embryonic-Like (VSEL) stem cell
Amgen teams with NASA on a new biotech space mission
The final mission on NASA's 30-year Space Shuttle program will blast off with a biotech experiment in its payload. Scientists from Amgen, UCB as well as academia are dispatching a team of 30 mice
Radius lands $91M, plans listing as it plots Ph3 osteoporosis drug trial
Poised at the threshold of a late-stage trial for its lead drug, Cambridge, MA-based Radius Health has wrapped a $91 million financing round with $66 million in equity funding and a $25 million loan
Docs revisit strategies for bone-drug use
The popularity and effectiveness of bisphsophonate drugs such as Fosamax for generally healthy women without osteoporosis or broken bones have become a source of increasing argument in doctors'
